1,942 reports of this reaction
3.2% of all NALTREXONE reports
#4 most reported adverse reaction
ALCOHOLISM is the #4 most commonly reported adverse reaction for NALTREXONE, manufactured by Alkermes, Inc.. There are 1,942 FDA adverse event reports linking NALTREXONE to ALCOHOLISM. This represents approximately 3.2% of all 60,963 adverse event reports for this drug.
NALTREXONE has an overall safety score of 78 out of 100. Patients taking NALTREXONE who experience alcoholism should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ALCOHOLISM is moderately reported among NALTREXONE users, representing a notable but not dominant share of adverse events.
In addition to alcoholism, the following adverse reactions have been reported for NALTREXONE:
ALCOHOLISM has been reported as an adverse event in 1,942 FDA reports for NALTREXONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ALCOHOLISM accounts for approximately 3.2% of all adverse event reports for NALTREXONE, making it a notable side effect.
If you experience alcoholism while taking NALTREXONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.